DEPLETION OF C-MYC WITH SPECIFIC ANTISENSE SEQUENCES REVERSES THE TRANSFORMED PHENOTYPE IN RAS ONCOGENE-TRANSFORMED NIH 3T3 CELLS

被引:60
|
作者
SKLAR, MD
THOMPSON, E
WELSH, MJ
LIEBERT, M
HARNEY, J
GROSSMAN, HB
SMITH, M
PROCHOWNIK, EV
机构
[1] UNIV MICHIGAN,SCH MED,COMM CELL & MOLEC BIOL,ANN ARBOR,MI 48109
[2] UNIV MICHIGAN,SCH MED,DEPT PEDIAT,ANN ARBOR,MI 48109
[3] UNIV MICHIGAN,SCH MED,DEPT SURG,UROL SECT,ANN ARBOR,MI 48109
[4] UNIV MICHIGAN,SCH MED,DEPT RADIAT ONCOL,ANN ARBOR,MI 48109
[5] UNIV MICHIGAN,SCH MED,DEPT ANAT & CELL BIOL,ANN ARBOR,MI 48109
关键词
D O I
10.1128/MCB.11.7.3699
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ras oncogene-transformed NIH 3T3 cells expressing glucocorticoid-inducible antisense c-myc cDNA transcripts at levels sufficient to deplete c-myc protein lost their transformed morphology and the ability to grow in soft agar; their ability to form tumors in nude mice was also impaired. These changes were dependent on the continuous expression of the antisense sequences. No major effects on plating efficiencies, growth rates in monolayer culture, or immortalization were observed in the revertant cells, indicating that the observed effects were not a toxic consequence of c-myc protein depletion. Transfection with the same vector expressing c-myc in the sense orientation or other control vectors had no effect on transformation. These results suggest that a certain minimum level of expression of c-myc is required for the maintenance of ras transformation in NIH 3T3 cells.
引用
收藏
页码:3699 / 3710
页数:12
相关论文
共 50 条
  • [1] Differential induction of apoptosis in oncogene-transformed NIH 3T3 cells by methylmethanesulfonate
    Kuo, ML
    Chou, YW
    Chau, YP
    Meng, TC
    BIOCHEMICAL PHARMACOLOGY, 1996, 52 (03) : 481 - 488
  • [2] CONDITIONED MEDIUM FROM RAS ONCOGENE-TRANSFORMED NIH 3T3 CELLS INDUCES BONE-RESORPTION INVITRO
    KRIEGER, NS
    SUKHATME, VP
    BUSHINSKY, DA
    JOURNAL OF BONE AND MINERAL RESEARCH, 1990, 5 (02) : 159 - 164
  • [3] THE MECHANISMS OF ORNITHINE DECARBOXYLASE DEREGULATION IN C-HA-RAS ONCOGENE-TRANSFORMED NIH 3T3-CELLS
    HOLTTA, E
    SISTONEN, L
    ALITALO, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1988, 263 (09) : 4500 - 4507
  • [4] GROWTH-FACTOR REQUIREMENTS OF ONCOGENE-TRANSFORMED NIH 3T3 AND BALB-C 3T3 CELLS CULTURED IN DEFINED MEDIA
    ZHAN, X
    GOLDFARB, M
    MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (10) : 3541 - 3544
  • [5] INVASIVENESS AND CHEMOTACTIC ACTIVITY OF ONCOGENE TRANSFORMED NIH/3T3 CELLS
    MELCHIORI, A
    CARLONE, S
    ALLAVENA, G
    ARESU, O
    PARODI, S
    AARONSON, SA
    ALBINI, A
    ANTICANCER RESEARCH, 1990, 10 (01) : 37 - 44
  • [6] REDUCED MALIGNANCY OF RAS-TRANSFORMED NIH 3T3 CELLS EXPRESSING ANTISENSE OSTEOPONTIN RNA
    BEHREND, EI
    CRAIG, AM
    WILSON, SM
    DENHARDT, DT
    CHAMBERS, AF
    CANCER RESEARCH, 1994, 54 (03) : 832 - 837
  • [7] EXPRESSION OF ANTISENSE MESSENGER-RNA IN H-RAS TRANSFECTED NIH/3T3 CELLS DOES NOT SUPPRESS THE TRANSFORMED PHENOTYPE
    SALMONS, B
    GRONER, B
    FRIIS, R
    MUELLENER, D
    JAGGI, R
    GENE, 1986, 45 (02) : 215 - 220
  • [8] ISOLATION OF RECESSIVE (MEDIATOR-) REVERTANTS FROM NIH 3T3 CELLS TRANSFORMED WITH A C-H-RAS ONCOGENE
    YAMADA, H
    OMATAYAMADA, T
    WAKABAYASHIITO, N
    CARTER, SG
    LENGYEL, P
    MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (04) : 1822 - 1827
  • [9] EXPERIMENTAL METASTASIS OF ONCOGENE-TRANSFORMED NIH-3T3 CELLS IN CHICK-EMBRYO
    ENDO, Y
    SEIKI, M
    UCHIDA, H
    NOGUCHI, M
    KIDA, Y
    SATO, H
    MAI, M
    SASAKI, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (03): : 274 - 280
  • [10] ELEVATED GELSOLIN AND ALPHA-ACTIN EXPRESSION IN A FLAT REVERTANT R1 OF HA-RAS ONCOGENE-TRANSFORMED NIH/3T3 CELLS
    MULLAUER, L
    FUJITA, H
    SUZUKI, H
    KATABAMI, M
    HITOMI, Y
    OGISO, Y
    KUZUMAKI, N
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 171 (02) : 852 - 859